Developing and testing Collaborative Quality ImProvement initiative (C-QIP) for prevention of cardiovascular disease in India
Developing and testing Collaborative Quality ImProvement initiative (C-QIP) for prevention of cardiovascular disease in India
批准号:
10677651
负责人:
Kavita Singh
金额:
$6.92万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-07-27 至 2025-04-30
关键词:
AdherenceAdministratorAdrenergic beta-AntagonistsAgeAmbulatory CareAngiotensin-Converting Enzyme InhibitorsAsiaAspirinAwardCardiovascular AgentsCardiovascular DiseasesCardiovascular systemCaringCase ManagerCause of DeathCessation of lifeCharacteristicsChronicChronic CareClinicClinicalClinical Decision Support SystemsClinical ResearchCollaborationsComplementComplexComputer softwareCountryDecision AidDevelopmentDisease OutcomeEconomicsEducational workshopEffectivenessEnrollmentEpidemicEuropeEuropeanEventFeedbackFogarty International CenterFoundationsFutureGoalsGovernmentGrantGrowthGuidelinesHealthHealth Care CostsHealth PersonnelHealth Services ResearchHealth systemHealthcareHealthcare SystemsHeart failureHeterogeneityIncomeIndiaIndividualInfrastructureInstitutionInternationalInterventionKnowledgeLearningLife StyleMeasuresMedical ResearchMentorsMissionModelingMorbidity - disease rateMyocardial InfarctionMyocardial IschemiaOnline SystemsOutcomeOutpatientsParticipantPatient CarePatientsPersonsPharmaceutical PreparationsPhysical activityPilot ProjectsPremature MortalityPreventionPrevention programPrivatizationProcessProcess MeasureProgram EvaluationProviderQuality of CareQuality of lifeRecurrenceReportingResearchResearch EthicsResearch PersonnelResearch TrainingResourcesRiskRuralSecondary PreventionSourceSouth AsianSoutheastern AsiaStandardizationStrokeTestingText MessagingTimeTrainingUnited KingdomUnited StatesUnited States National Institutes of HealthWorld Health Organizationacceptability and feasibilityadherence rateblood pressure reductionburden of illnesscardiovascular disorder epidemiologycardiovascular disorder preventioncardiovascular disorder therapycardiovascular healthcare costscare deliverycareercareer developmentchronic care modelcostdisabilityeffective interventionefficacy trialepidemiology studyevaluation/testingexperiencefeasibility testingglobal healthgood dietgroup interventionhealth care deliveryhealth organizationhealth related quality of lifehealthy lifestyleimplementation fidelityimplementation scienceimprovedimproved outcomeinnovationknowledge translationlifestyle interventionliteracylow and middle-income countriesmHealthmortalitymultidisciplinarynovelpragmatic interventionprocess improvementproductivity lossprogramsprospectivesmoking cessationsocialstress managementsystematic reviewteam-based caretreatment as usualtrial comparing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The proposed K43 application aims to develop, implement, and evaluate a
Collaborative Quality ImProvement (C-QIP) intervention (non-physician health worker, text
messages for healthy lifestyle and clinical decision-support system) effect on processes of care
measures and clinical outcomes among individuals with existing CVD in India using United Kingdom
Medical Research Council (MRC) framework for developing and evaluating complex interventions. A
growing body of research suggests several factors at the level of the patient, provider, and health
system may effectively lower the impact of CVD in India, such as literacy, increased time spent with
patients, and integrated health care. Maximizing CVD treatment in India must involve a cascade of
processes from appropriate prescribing to longer-term adherence as well as low(er)-cost health
service delivery innovations such as non-physician health workers and interactive web-based or
mHealth-based clinical decision-support system for providers and patients. Multifaceted quality
improvement intervention (including but not limited to non-physician health worker/case managers,
team-based care, SMS reminders, interactive decision-aids for patients and providers, audit-and
feedback mechanisms) have been successful in high-income countries for improving care among
individuals with existing CVD, but have not been extensively evaluated in India. These interventions
could be sources of innovation in CVD prevention, treatment, and control through implementation
science research.
During the career development period of this award, I will take courses in research
ethics, program evaluation, and health services research to complement my prior training. I will
participate in training, or workshops organized by the World Health Organization SEARO (South-East
Asia Regional Office), to learn about the development of evidence-informed clinical standards and
guidelines adapted to local country settings and healthcare systems.
My unique background and training will serve as a strong foundation for the present
proposal and for future career development as an independent, innovative investigator and leader in
global CVD research. In 10 years, I envision myself as an India-based clinical researcher in global
CVD epidemiology and prevention, with a focus in South Asia. My current and future training,
institution, and mentoring team provide me excellent platform to discover novel ideas about improving
cardiovascular health and ultimately disseminate and deliver them globally, including in the US. The
NIH K43 grant can provide me the mentored clinical research training and research opportunities to
pursue my career goals.
Relevance
Development of local solutions to improving CVD care by Indian practitioners may
provide innovative ideas that are relevant to and applicable in the US. As such, this proposal aims to
improve the delivery of chronic care for patients with CVD in India and capture the innovative potential
of global health, a thematic goal of the NIH and part of the strategic mission of the Fogarty
International Centre.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1186/s12905-022-01881-0
发表时间:
2022-07-25
期刊:
BMC WOMENS HEALTH
影响因子:
2.5
作者:
[Isabirye, Alone, Elwange, Bob Charlestine, Singh, Kavita, De Allegri, Manuela]
通讯作者:
De Allegri, Manuela
DOI:
10.1136/bmjopen-2021-056408
发表时间:
2022-07-07
期刊:
BMJ OPEN
影响因子:
2.9
作者:
[Mohan, Bishav, Singh, Bhupinder, Singh, Kavita, Naik, Nitish, Roy, Ambuj, Goyal, Abhishek, SIngh, Gurbhej, Aggarwal, Shivaansh, Saini, Aftabh, Tandon, Rohit, Chhabra, Shibba Takkar, Aslam, Naved, Wander, Gurpreet Singh, Prabhakaran, Dorairaj]
通讯作者:
Prabhakaran, Dorairaj
DOI:
10.5334/gh.1128
发表时间:
2022
期刊:
GLOBAL HEART
影响因子:
3.7
作者:
[Prabhakaran, Dorairaj, Singh, Kavita, Kondal, Dimple, Raspail, Lana, Mohan, Bishav, Kato, Toru, Sarrafzadegan, Nizal, Talukder, Shamim hayder, Akter, Shahin, Amin, Mohammad Robed, Goma, Fastone, Gomez-Mesa, Juan, Ntusi, Ntobeko, Inofomoh, Francisca, Deora, Surender, Philippov, Evgenii, Svarovskaya, Alla, Konradi, Alexandra, Puentes, Aurelio, Ogah, Okechukwu S., Stanetic, Bojan, Issa, Aurora, Thienemann, Friedrich, Juzar, Dafsah, Zaidel, Ezequiel, Sheikh, Sana, Ojji, Dike, Lam, Carolyn S. P., Ge, Junbo, Banerjee, Amitava, Newby, L. Kristin, Ribeiro, Antonio Luiz P., Gidding, Samuel, Pinto, Fausto, Perel, Pablo, Sliwa, Karen]
通讯作者:
Sliwa, Karen
Cardiovascular health metrics in low and middle-income countries: A scoping review.
低收入和中等收入国家的心血管健康指标:范围界定审查。
DOI:
10.1016/j.ypmed.2023.107534
发表时间:
2023
期刊:
Preventive medicine
影响因子:
5.1
作者:
[Garegnani,Luis, Franco,JuanVíctorAriel, EscobarLiquitay,CamilaMicaela, Brant,LuisaCamposCaldeira, Lim,HooiMin, deJesusJessen,NeusaPerina, Singh,Kavita, Ware,LisaJayne, Labarthe,Darwin, Perman,Gastón]
通讯作者:
Perman,Gastón
DOI:
10.3389/fpubh.2021.682203
发表时间:
2021
期刊:
Frontiers in public health
影响因子:
5.2
作者:
[Mishra P, Greenfield SM, Harris T, Hamer M, Lewis SA, Singh K, Nair R, Mukherjee S, Krishnamurthy Manjunath N, Harper DR, Tandon N, Kinra S, Prabhakaran D, Chattopadhyay K]
通讯作者:
Chattopadhyay K
共 20 条
Developing and testing Collaborative Quality ImProvement initiative (C-QIP) for prevention of cardiovascular disease in India
-
批准号:10160984
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2019
-
负责人:Kavita Singh
-
依托单位:
Developing and testing Collaborative Quality ImProvement initiative (C-QIP) for prevention of cardiovascular disease in India
-
批准号:10418718
-
项目类别:
-
资助金额:$6.89万
-
财政年份:2019
-
负责人:Kavita Singh
-
依托单位:
海外基金